FDA Inspection
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. – FDA Inspection, Sep 15, 2017
Record Details
This FDA Inspection record concerns Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd., with an inspection on September 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 15, 2017
- Product Type
- Drugs
View Company Profile
ID · 1f0a551c-0bea-40b7-8a2c-5fa22d58b93c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1032045
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| June 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.